Jubilant Life sciences

To tide over the COVID-19 pandemic led crisis, the company in the near-term is deferring its major CAPEX plans, informs annual…

The company will make the drug available to over 1,000 hospitals providing COVID-19 treatment in India through its distribution…

The company will distribute the drug in the Indian market through its distribution network and will be available by the first week…

The licence is royalty-free until another pharma product or vaccine is approved for the treatment or prevention of COVID-19 by the…

Inspite of challenges, pharma biz segment growth likely to be healthy: ICICI Securities

The contribution of Jubilant Life Sciences, along with all its subsidiaries, includes one day gross salary of its 5300 employees

None of the employees tested positive so far travelled overseas in the last six month, the company announced in a press release

Jubilant is the second largest producer of Vitamin B3 globally

The payments are on account of an acquisition by a large pharma company of one of their investee companies having assets in early…

In Q2 FY16, the company's consolidated revenue was at Rs 1,463 crore The board of Jubilant Life Sciences recently met to approve…